Bigul

GKB OPHTHALMICS LTD. - 533212 - Closure of Trading Window

Dear Sir, Pursuant to SEBI( Prohibition of Insider Trading) Regulation 2015, as amended from time to time, the "Trading Window" for dealing /trading in the shares of the Company shall remain closed from July 01, 2024, till the completion of 48 hours after the declaration of the financial results of the Company \, for the first quarter ended June 30, 2024. Accordingly, all the Promoters, Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading Window. Further the date of Board meeting at which the said results will be considered , shall be intimated in due course of time. Kindly take the information on record.
28-06-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that our Registrar and Transfer Agent viz. Link Intime India Private Limited vide email dated June 27, 2024 has informed us regarding the loss of share certificate and request for issue of duplicate share certificate to Mr. Dilnavaz Shroff,shareholder of the Company. Our Registrar and Share Transfer Agent has noted pertaining to stop Transfer in its database. The copy of email received from link Intime India Private limited, Registrar & Share Transfer Agent , is enclosed herewith Kindly take the information on record.
27-06-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

Dear Sir, Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation, 2015, intimation be and hereby given that Mr. Cedric Lobo, Director of the Company ,has purchased 400 equity shares aggregating to Rs. 38,424/- on 19.06.2024 of the Company ,on market. Copy of disclosure required under Regulation 7(1) (a) read with Regulation 6(2) of SEBI (Initial disclosure to the company) Regulation ,2015, received from Mr. Cedric Lobo, is enclosed herewith. Please acknowledge and take the same on record,
20-06-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

Dear sir, Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI(Prohibition of Insider Trading) Regulation, 2015, intimation be and is hereby given that Mr. Gurudas Sawant Chief Financial Officer(KMP) of the Company, has purchased 425 equity shares aggregating to Rs. 40,336/- on 19.06.2024,of the Company,on market. Copy of disclosure required under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations,2015, is enclosed herewith. Copy of disclosure received from Mr. Gurudas Sawant, is also enclosed herewith. Please acknowledge and take the same on record
20-06-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Extract Of Statement Of Audited Standalone And Consolidated Financial Results For The Year Ended March 31, 2024.

Dear Sir, Please find attached copies of newspaper cuttings of the extract of Statement of audited Standalone and Consolidated Financial Results for the year ended March 31, 2024, published in The Financial Express(Mumbai Edition) and on Pudhari (Marathi) dated June 01, 2024. Please acknowledge receipt.
03-06-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - GKB- Submission Of Consolidated Related Party Transactions For The Half Year Ended March 31, 2024

Dear Sir, Enclosed please find the Consolidated Related Party Transactions for the half year ended March 31, 2024. Kindly take the information on record.
30-05-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Statement Of Deviation(S) And Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations, 2015 - March 31, 2024

Dear Sir, Enclosed please find the Statement of Deviation(s) and Variation(s) under Regulation 32 of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended March 31, 2024. Kindly take the above information on record.
30-05-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Dear Sir, Attached please find the Annual Secretarial Compliance Report for the year ended March 31, 2024. Kindly take the above information on record.
30-05-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - GKB - Audited Standalone And Consolidated Financials For The Quarter And Year Ended March 31, 2024

Dear Sir, Enclosed Please find the Audited Standalone and Consolidated Financials for the quarter and year ended March 31, 2024. Kindly take the information on record.
30-05-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On May 30, 2024.

The meeting of the Board of Directors of the Company was held on May 30, 2024, which approved and took on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following: 1. Standalone Financial Results for the quarter and year ended March 31, 2024, together with Auditors'' Report. 2. Consolidated Financial Results for the quarter and year ended March 31, 2024, together with Auditors'' Report. 3. A declaration from CFO with respect to Audit Report with unmodified opinion for the financial year ended March 31, 2024, in terms of SEBI Circular no. CIR/ CFD/CMD/56/2016 dated May 27, 2016. The above Audited Financial Results and Auditors'' Reports'' are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com
30-05-2024
Next Page
Close

Let's Open Free Demat Account